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Figure 2. (A) Phage adsorption. (B) OSGC. (C) Effect of RJ on API480
concentration. (D) Effect of acidic pH in API480 concentration.
References Acknowledgements
[1] Genersch, E. (2010). American Foulbrood in honeybees and its causative agent, Paenibacillus larvae. [2] Beims, H. et al. (2015). Paenibacillus larvae-
Directed bacteriophage HB10c2 and its application in American foulbrood-affected honey bee larvae. [3] Ghorbani-Nezami, S. et al. (2015). Phage therapy
is effective in protecting honeybee larvae from American foulbrood disease. [4] Yost, D. G. et al. (2016). Experimental bacteriophage treatment of
honeybees (Apis mellifera) infected with Paenibacillus larvae, the causative agent of American foulbrood disease. [5] Brady, T. S. et al. (2017).
Bacteriophages as an alternative to conventional antibiotic use for the prevention or treatment of Paenibacillus larvae in honeybee hives. [6] Stamereilers,
C. et al. (2018). Genomic Analysis of 48 Paenibacillus larvae Bacteriophages.
This work was supported by the project APILYSE, PTDC/CVT-EPI/4008/2014 - POCI-01-0145-FEDER-016598, - funded by FEDER through COMPETE 2020 -
Programa Operacional Competitividade e Internacionalização (POCI) and the Portuguese Foundation for Science and Technology (FCT) under the scope of
the strategic funding of UID/BIO/04469/2019 unit and BioTecNorte operation (NORTE-01-0145-FEDER-000004) funded by the European Regional
Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte. The work was also supported by CEB-UM that provided the
laboratorial facilities to perform this research. HR was supported by FCT through the grant SFRH/BD/128859/2017. MB and RL were supported by KU
Leuven through a GOA grant [3E140356].
Introduction
Goal of the study
Results
Main conclusions
Methods
Bacteriophage
Biotechnology
Group
C
A B
D
American foulbrood disease (AFB) is a devastating bacterial disease affecting honeybees. It is caused by Paenibacillus larvae, a worldwide-distributed spore forming
Gram-positive bacterium which spread easily across apiaries producing highly resistant spores. When AFB symptoms are found the burning of contaminated hives is
mandatory causing serious economic losses [1]. Bacteriophages (phages) are being considered valuable solutions to the control of this infection [2-5]. So far, 48
Siphoviridae P. larvae phages sequences are known and most encode integration genes suggesting a temperate lifestyle. All of these 48 phages seem to have a common
evolutionary ancestor showing an overall common structure. Their genomes were grouped into four clusters (with Fern, Harrison, Vegas and Halcyone as representative
phages) and one singleton (phage Lily) [6].
The main goal of this study was
the characterization of the first
podovirus infecting P. larvae
(API480), envisaging AFB control.
Phage isolation
Genome sequencing, annotation and 
compative analysis
Phage characterization
Phage viability in simulated field 
conditions
• TEM
• Lytic spetra, EOP
• Adsorption, OSGC (MOI=0.1)
• Specificity test
• 50% (w/v) sucrose
• Larval homogenised
• Royal jelly (RJ)
• pH solutions (universal buffer) ranging 
3.0 to 5.0
• Statistical significance (p<0.05)
Culture condictions:
• MYPGP medium
• 37ºC, 5% CO2, O/N
Illumina MiSeq
• API480 is a distinct phage (4% genome coverage and 14% shared proteins), suggesting the creation of a new species within the Podoviridae family.
• Besides no lysogenic module being identified, API480 is a temperate phage.
• API480 has a broad lytic spectrum and is specific to P. larvae. The larval commensal (L. kunkeei and P. apium) are not affected by this phage.
• This phage is very stable when exposed to high sucrose concentration and to larval homogenized content.
• Overall, results suggest that this phage holds potential to be used in the biocontrol of American Foulbrood disease.
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Figure 1. (A) Pairwise genome maps of API480 with the closest relatives phages. (B) TEM
micrograph showing the virion particle morphology. (C) Relationship of shared gene content
from a total 49 P. larvae phages. (D) API480 lytic spectra and EOP (susceptible (+), non-
susceptible (-) and lysis from without (LFW)).
No negative effects caused in API480 phage viability by 
sucrose and larval homogenate after 24 hours.
Cut-off of > 40% homology 
individual cluster
PHAMERATOR
107 PFU.mL-1
1, 3, 6, 8, 24 h
...
“a” - same pH for each timepoint; “b” – same timepoint, subsequent pH value. 
LOD = 1 Log.Limit of detection (LOD) = 3 Log.
Species
No. 
strain
Score
P. larvae 19 LFW
P. larvae 42 +
L. pentosus 1 -
L. rhamnosus 1 -
L. paracasei 1 -
L. casei 1 -
L. acidophilus 1 -
L. kunkeei 1 -
B. subtilis 1 -
B. cereus 1 -
B.  circulans 1 LFW
B. coagulans 1 LFW
P. apium 1 -
P. polymyxa 1 -
P. alvei 1 -
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